
Health Technology Holding (HTH)
Hands-on formative-stage life‑science investor and advisor delivering deep, science-driven due diligence (PoC, MoA, animal models, KOL/clinician interviews) and access to pharma, corporate partnerships and stakeholder networks. With a disciplined investment approach, the team drives value for both founders and investors.
- Cheque size
- $500K – $1M
- Industries
- Not specified
- Operating in
- How they invest
- Not specified
- Technologies
- Not specified

